baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

L&S Knock-Out Nel ASA/ DE000LX346A6 /

8/3/2024 1:03:34 PM	Chg.0.000	Bid1:03:34 PM	Ask1:03:34 PM	Underlying	Strike price	Expiration date	Option type
0.140EUR	0.00%	0.140 Bid Size: -	0.160 Ask Size: -	-	0.3685 EUR	12/31/2078	Call

GlobeNewswire 5/23/2008 DISTRIBUTION AGREEMENT FOR INDIA

GlobeNewswire 4/30/2008 REPORT FOR FIRST QUARTER 2008

GlobeNewswire 2/15/2008 REPORT FOR FOURTH QUARTER 2007

GlobeNewswire 2/4/2008 DIAGENIC ANNOUNCES PRELIMINARY RESULTS FROM A MULTICENTRE BREAST CANCER STUDY IN INDIA

GlobeNewswire 12/20/2007 Parkinson to become third product - US funding and co-operation

GlobeNewswire 10/26/2007 Report for third quarter 2007

GlobeNewswire 8/16/2007 Report for second quarter 2007

GlobeNewswire 5/14/2007 ANNUAL REPORT 2006 - NOTICE OF ANNUAL GENERAL MEETING

GlobeNewswire 7/18/2006 PRESENTATION OF RESULTS ON ALZHEIMER'S DISEASE

GlobeNewswire 7/6/2006 ALZHEIMER'S DISEASE - SCIENTIFIC ADVISORY BOARD

GlobeNewswire 5/5/2006 PRESENTATION OF RESEARCH RESULTS

GlobeNewswire 5/3/2006 DIAGENIC ASA - NOTICE OF ANNUAL GENERAL MEETING

GlobeNewswire 4/3/2006 PRESS RELEASE

GlobeNewswire 3/17/2006 Private placement and insider sale completed

GlobeNewswire 1/31/2006 RESULTS - ALZHEIMER'S DISEASE

GlobeNewswire 1/6/2006 AWARD OF PUBLIC FUNDING OF NOK 9,76 MILLION

GlobeNewswire 9/9/2005 PRODUCT DEVELOPMENT AGREEMENT

GlobeNewswire 3/3/2005 CONFIRMATION ON A COMMERCIAL PLATFORM

L&S Knock-Out Nel ASA/ DE000LX346A6 /

If you wish to receive reply to your feedback, please provide your email address.